AWD-12250

N/A

Report date: 2024/12/19 17:16:17
NME

Base Information

Drug NameAWD-12250
Drug Alias NameAWD-12-250
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 3 inhibitorsPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 3Phosphodiesterase 5A
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElbion
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElbion
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A